Paying users zone. Data is covered by 
.
Get 1 month access to Regeneron Pharmaceuticals Inc. for $13.99, or
get full access to entire website for at least 3 months from $49.99.
We accept:
Regeneron Pharmaceuticals Inc. (REGN)
Long-term (Investment) Activity Analysis
Difficulty: Beginner
Activity ratios measure how efficiently a company performs day-to-day tasks, such us the collection of receivables and management of inventory.
Ratios (Summary)
Regeneron Pharmaceuticals Inc., long-term (investment) activity ratios
| Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 | Dec 31, 2014 | ||
|---|---|---|---|---|---|---|
| Net fixed asset turnover | |
|
|
|
|
|
| Total asset turnover | |
|
|
|
|
|
| Equity turnover | |
|
|
|
|
Based on: 10-K (filing date: 2019-02-07), 10-K (filing date: 2018-02-08), 10-K (filing date: 2017-02-09), 10-K (filing date: 2016-02-11), 10-K (filing date: 2015-02-12).
| Ratio | Description | The company |
|---|---|---|
| Net fixed asset turnover | An activity ratio calculated as total revenue divided by net fixed assets. | Regeneron Pharmaceuticals Inc.’s net fixed asset turnover improved from 2016 to 2017 and from 2017 to 2018. |
| Total asset turnover | An activity ratio calculated as total revenue divided by total assets. | Regeneron Pharmaceuticals Inc.’s total asset turnover deteriorated from 2016 to 2017 and from 2017 to 2018. |
| Equity turnover | An activity ratio calculated as total revenue divided by shareholders’ equity. | Regeneron Pharmaceuticals Inc.’s equity turnover deteriorated from 2016 to 2017 and from 2017 to 2018. |
Net Fixed Asset Turnover
Regeneron Pharmaceuticals Inc., net fixed asset turnover calculation, comparison to benchmarks
Based on: 10-K (filing date: 2019-02-07), 10-K (filing date: 2018-02-08), 10-K (filing date: 2017-02-09), 10-K (filing date: 2016-02-11), 10-K (filing date: 2015-02-12).
2018 Calculations
1 Net fixed asset turnover = Revenues ÷ Property, plant, and equipment, net
= ÷ =
| Ratio | Description | The company |
|---|---|---|
| Net fixed asset turnover | An activity ratio calculated as total revenue divided by net fixed assets. | Regeneron Pharmaceuticals Inc.’s net fixed asset turnover improved from 2016 to 2017 and from 2017 to 2018. |
Total Asset Turnover
Regeneron Pharmaceuticals Inc., total asset turnover calculation, comparison to benchmarks
Based on: 10-K (filing date: 2019-02-07), 10-K (filing date: 2018-02-08), 10-K (filing date: 2017-02-09), 10-K (filing date: 2016-02-11), 10-K (filing date: 2015-02-12).
2018 Calculations
1 Total asset turnover = Revenues ÷ Total assets
= ÷ =
| Ratio | Description | The company |
|---|---|---|
| Total asset turnover | An activity ratio calculated as total revenue divided by total assets. | Regeneron Pharmaceuticals Inc.’s total asset turnover deteriorated from 2016 to 2017 and from 2017 to 2018. |
Equity Turnover
Regeneron Pharmaceuticals Inc., equity turnover calculation, comparison to benchmarks
Based on: 10-K (filing date: 2019-02-07), 10-K (filing date: 2018-02-08), 10-K (filing date: 2017-02-09), 10-K (filing date: 2016-02-11), 10-K (filing date: 2015-02-12).
2018 Calculations
1 Equity turnover = Revenues ÷ Stockholders’ equity
= ÷ =
| Ratio | Description | The company |
|---|---|---|
| Equity turnover | An activity ratio calculated as total revenue divided by shareholders’ equity. | Regeneron Pharmaceuticals Inc.’s equity turnover deteriorated from 2016 to 2017 and from 2017 to 2018. |